The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Evolving knowledge of the teratogenicity of medications in human pregnancy
Abstract
A majority of pregnant women take at least one medication during pregnancy, although the safety of such drugs during pregnancy is not always known. We reviewed the safety during pregnancy of 172 drugs approved by the US Food and Drug Administration (FDA) from 2000 to 2010 using the TERIS risk rating system. We also reviewed safety information for 468 drugs approved by the FDA from 1980 to 2000 to determine if revisions in risk categories had been made in the last 10 years. The teratogenic risk in human pregnancy was “undetermined” for 168 (97.7%) of drug treatments approved between 2000 and 2010. Furthermore, the amount of data available regarding safety in pregnancy was rated as “none” for 126 (73.3%) of these drugs. For those drugs approved between 1980 and 2000, only 23 (5%) changed a full risk category or more in the past 10 years. Sources of data that led to a revised risk were derived from exposure cohort studies performed through record linkage studies, teratogen information services, large population‐based case‐control studies, and pregnancy registries. The mean time for a treatment initially classified as having an “undetermined” risk to be assigned a more precise risk was 27 years (95% confidence interval 26–28 years). The lack of information needed to assess the safety of drug treatments during human pregnancy remains a serious public health problem. A more active approach to post‐marketing surveillance for teratogenic effects is necessary. © 2011 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Methods for Rates and Proportions.
Everitt, B. S., & Fleiss, J. L. (1981) · Biometrics · doi:10.2307/2530193 · Cited by 8,990
Major congenital malformations after first-trimester exposure to ACE inhibitors
Cooper, W. O., Hernandez-Diaz, S., Arbogast, P. G., Dudley, J. A., Dyer, S., Gideon, P. S., Hall, K., & Ray, W. A. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055202 · Cited by 1,192
Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008
Mitchell, A. A., Gilboa, S. M., Werler, M. M., Kelley, K. E., Louik, C., & Hernández-Díaz, S. (2011) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2011.02.029 · Cited by 813
The National Birth Defects Prevention Study
Yoon, P., Rasmussen, S., Lynberg, M., Moore, C., Anderka, M., Carmichael, S., Costa, P., Druschel, C., Hobbs, C., Romitti, P., et al. (2001) · Public Health Reports® · doi:10.1093/phr/116.s1.32 · Cited by 692
Prescription drug use in pregnancy
Andrade, S. E., Gurwitz, J. H., Davis, R. L., Chan, K. A., Finkelstein, J. A., Fortman, K., McPhillips, H., Raebel, M. A., Roblin, D., Smith, D. H., et al. (2004) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.04.025 · Cited by 564
Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk
Gilbert-Barness, E. (1996) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.1996.02170300118039 · Cited by 459
Use of over-the-counter medications during pregnancy
Werler, M. M., Study, T. N. B. D. P., Mitchell, A. A., Hernandez-Diaz, S., & Honein, M. A. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2005.02.100 · Cited by 380
Angiotensin II receptor antagonist treatment during pregnancy
Alwan, S., Polifka, J. E., & Friedman, J. M. (2005) · Birth Defects Research Part A: Clinical and Molecular Teratology · doi:10.1002/bdra.20102 · Cited by 247
Self-citationChemically Induced Birth Defects
Schardein, J. (2000) · CRC Press eBooks · doi:10.3109/9780203909904 · Cited by 242
Drugs During Pregnancy and Lactation: Treatment Options and Risk Assessment
Schaefer, C. E., Peters, P. W. J., & Miller, R. K. (2011) · Cited by 205
Paper 1: The EUROCAT network—organization and processes†
Boyd, P. A., Haeusler, M., Barisic, I., Loane, M., Garne, E., & Dolk, H. (2011) · Birth Defects Research Part A: Clinical and Molecular Teratology · doi:10.1002/bdra.20780 · Cited by 167
Prescription drug use during pregnancy: a population-based study in Regione Emilia-Romagna, Italy
Gagne, J. J., Maio, V., Berghella, V., Louis, D. Z., & Gonnella, J. S. (2008) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-008-0546-y · Cited by 135
Weber-Schoendorfer, C., Hannemann, D., Meister, R., Eléfant, E., Cuppers-Maarschalkerweerd, B., Arnon, J., Vial, T., Rodriguez-Pinilla, E., Clementi, M., Robert-Gnansia, E., et al. (2008) · Reproductive Toxicology · doi:10.1016/j.reprotox.2008.05.065 · Cited by 104 · cited 1×
“…2001; Kubicsek et al., 2010; Boyd et al., 2011], and many prospective exposure cohort studies of pregnancy outcomes following treatment with prescription medications have been performed through teratology information services [Weber-Schoendorfer et al., 2008; Hancock et al., 2010; Chambers, 2011].”
BackgroundUse of prescription and non-prescription drugs in pregnancy
Rubin, J. D., Ferencz, C., & Loffredo, C. A. (1993) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(93)90132-k · Cited by 96
Chambers, C., Tutuncu, Z. N., Johnson, D., & Jones, K. L. (2006) · Arthritis Research & Therapy · doi:10.1186/ar1977 · Cited by 88
Olesen, C., Sørensen, H. T., den Berg, L. D. J., Olsen, J., Steffensen, F. H., & The Euromap Group (1999) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1034/j.1600-0412.1999.780805.x · Cited by 61
Colvin, L., Slack-Smith, L. M., Stanley, F. J., & Bower, C. I. (2010) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1995 · Cited by 50
Prescription drugs and pregnancy
Webster, W. S., & Freeman, J. A. (2003) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.4.6.949 · Cited by 50
Medical databases in studies of drug teratogenicity: methodological issues
Ehrenstein, V. (2010) · Clinical Epidemiology · doi:10.2147/clep.s9304 · Cited by 42
Scialli, A. R., Buelke‐Sam, J., Chambers, C., et al. (2004) · Birth Defects Research Part A Clinical and Molecular Teratology · doi:10.1002/bdra.10150 · Cited by 41
Buhimschi, C. S., & Weiner, C. P. (2009) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e31818d686c · Cited by 38
Hancock, R., Ungar, W. J., Einarson, A., & Koren, G. (2010) · Journal of Evaluation in Clinical Practice · doi:10.1111/j.1365-2753.2009.01238.x · Cited by 16
Kubicsek, T., Kazy, Z., & Czeizel, A. E. (2010) · Reproductive Toxicology · doi:10.1016/j.reprotox.2010.12.001 · Cited by 14
Cited by
Medication use in pregnancy: a cross-sectional, multinational web-based study
Lupattelli, A., Spigset, O., Twigg, M. J., Zagorodnikova, K., Mårdby, A. C., Moretti, M. E., Drozd, M., Panchaud, A., Hämeen-Anttila, K., Rieutord, A., et al. (2014) · BMJ Open · doi:10.1136/bmjopen-2013-004365 · Cited by 495
Prenatal paracetamol exposure and child neurodevelopment: A review
Bauer, A. Z., Kriebel, D., Herbert, M. R., Bornehag, C.-G., & Swan, S. H. (2018) · Hormones and Behavior · doi:10.1016/j.yhbeh.2018.01.003 · Cited by 127
Metadata
- Authors
- Adam, M. P., Polifka, J. E., & Friedman, J. M.
- Venue
- American Journal of Medical Genetics Part C: Seminars in Medical Genetics
- Publisher
- Wiley
- Published
- 2011-07-15
- Volume
- 157
- Issue
- 3
- Pages
- 175-182
- ISSN
- 1552-4868 (ISSN-L)
- 1552-4876
- OpenAlex
- W2056105302
- Cited by
- 376
- References
- 23
- FWCI
- 14.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.